Altered expression of early cardiac marker genes in circulating cells of patients with hypertrophic cardiomyopathy

Cardiovascular Pathology

Volumn 16, Issue 6, 2007, Pages 329-335

  Kontaraki, Joanna E ^a   Parthenakis, Fragiskos I ^a   Patrianakos, Alexandros P ^a   Karalis, Ioannis K ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Blood; Early cardiac marker genes; Gene expression; Hypertrophic cardiomyopathy

Indexed keywords

MYOCARDIN; MYOCYTE ENHANCER FACTOR 2; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5;

ADULT; AGED; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MUTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HEART VENTRICLES; HOMEODOMAIN PROTEINS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LEUKOCYTES, MONONUCLEAR; MADS DOMAIN PROTEINS; MALE; MIDDLE AGED; MYOGENIC REGULATORY FACTORS; MYOSIN HEAVY CHAINS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 36048998510     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2007.04.004     Document Type: Article

References (51)

1. Epstein N., and Davis J. Sensing stretch is fundamental. Cell 112 (2003) 147-150
2. McKinsey T., Zhang C., and Olson E. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27 (2002) 40-47
3. Marks A. Calcium and the heart: a question of life and death. J Clin Invest 111 (2003) 597-600
4. Olson E., and Schneider M. Sizing up the heart: development redux in disease. Genes Dev 17 (2003) 1937-1956
5. Hunter J., and Chien K. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341 (1999) 1276-1283
6. Charron P., and Komajda M. Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease. Expert Rev Mol Diagn 6 (2006) 65-78
7. Frey N., Katus H., Olson E., and Hill J. Hypertrophy of the heart: a new therapeutic target?. Circulation 109 (2004) 1580-1589
8. Hwang D., Dempsey A., Wang R.-X., Rezvani M., Barrans J., Mhsc J., et al. A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. Circulation 96 (1997) 4146-4203
9. Barrans J., Allen P., Stamatiou D., Dzau V., and Liew C.-C. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol 160 (2002) 2035-2043
10. Hwang J.-J., Allen P., Tseng G., Lam C.-W., Fananapazir L., Dzau V., et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 10 (2002) 31-44
11. Tan F.-L., Moravec C., Li J., Apperson-Hansen C., McCarthy P., Young J., et al. The gene expression fingerprint of human heart failure. PNAS 99 (2002) 11387-11392
12. Seo D., Ginsburg G., and Goldschmidt-Clermont P. Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications. J Am Coll Cardiol 48 (2006) 227-235
13. Barth A., Kuner R., Buness A., Ruschhaupt M., Merk S., Zwermann L., et al. Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. J Am Coll Cardiol 48 (2006) 1610-1617
14. Ginsburg G., Seo D., and Frazier C. Microarrays coming of age in cardiovascular medicine: standards, predictions, and biology. J Am Coll Cardiol 48 (2006) 1618-1620
15. Whitney A., Diehn M., Popper S., Alizadeh A., Boldrick J., Relman D., et al. Individuality and variation in gene expression patterns in human blood. PNAS 100 (2003) 1896-1901
16. Damas J., Gullestad L., Aass H., Simonsen S., Fjeld J., Wikeby L., et al. Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure-modulatory effect of intravenous immunoglobulin. J Am Coll Cardiol 38 (2001) 187-193
17. Patino W., Mian O., Kang J.-G., Matoba S., Bartlett L., Holbrook B., et al. Circulating transcriptome reveals markers of atherosclerosis. PNAS 102 (2005) 3423-3428
18. Mehra M. The emergence of genomic and proteomic biomarkers in heart transplantation. J Heart Lung Transplant 24 (2005) S213-S218
19. Deng M., Eisen H., Mehra M., Billingham M., Marboe C., Berry G., et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6 (2006) 150-160
20. Mehra M., Uber P., Walther D., Vesely M., Wohlgemuth J., Prentice J., et al. Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker. Circulation 114 (2006) I21-I26
21. Latif S., Masino A., and Garry D. Transcriptional pathways direct cardiac development and regeneration. Trends Cardiovasc Med 16 (2006) 234-240
22. Konhilas J., and Leinwand L. Partnering up for cardiac hypertrophy. Circ Res 98 (2006) 985-987
23. Heineke J., and Molkentin J. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7 (2006) 589-600
24. Liu F., Ismat F., and Patel V. Role of homeodomain-only protein in the cardiac conduction system. Trends Cardiovasc Med 16 (2006) 193-198
25. Oka T., Xu J., and Molkentin J. Re-employment of developmental transcription factors in adult heart disease. Semin Cell Dev Biol 18 (2007) 117-131
26. Ritter O., and Neyses L. The molecular basis of myocardial hypertrophy and heart failure. Trends Mol Med 9 (2003) 313-321
27. Wamhoff B., Bowles D., and Owens G. Excitation-transcription coupling in arterial smooth muscle. Circ Res 98 (2006) 868-878
28. Maron B., and Epstein S. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 43 (1979) 1242-1244
29. Schiller N., Shah P., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
30. Devereux R., and Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 55 (1977) 613-618
31. t difference" formula. J Mol Med V84 (2006) 901-910
32. Pfaffl M. A new mathematical model for relative quantification in real-time RT-PCR. Nucl Acids Res 29 (2001) e45
33. Yuan J., Reed A., Chen F., and Stewart C. Statistical analysis of real-time PCR data. BMC Bioinformatics 7 (2006) 85
34. Chen F., Kook H., Milewski R., Gitler A., Lu M., Li J., et al. Hop is an unusual homeobox gene that modulates cardiac development. Cell 110 (2002) 713-723
35. Perrino C., and Rockman H. GATA4 and the two sides of gene expression reprogramming. Circ Res 98 (2006) 715-716
36. Song K., Backs J., McAnally J., Qi X., Gerard R., Richardson J., et al. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell 125 (2006) 453-466
37. Xing W., Zhang T.-C., Cao D., Wang Z., Antos C., Li S., et al. Myocardin induces cardiomyocyte hypertrophy. Circ Res 98 (2006) 1089-1097
38. Shin C., Liu Z.-P., Passier R., Zhang C.-L., Wang D.-Z., Harris T., et al. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110 (2002) 725-735
39. Oka T., Maillet M., Watt A., Schwartz R., Aronow B., Duncan S., et al. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res 98 (2006) 837-845
40. Hannenhalli S., Putt M., Gilmore J., Wang J., Parmacek M., Epstein J., et al. Transcriptional genomics associates FOX transcription factors with human heart failure. Circulation 114 (2006) 1269-1276
41. Torrado M., López E., Centeno A., Medrano C., Castro-Beiras A., and Mikhailov A. Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy. J Mol Med 81 (2003) 566-577
42. van Tuyn J., Knaan-Shanzer S., van de Watering M., de Graaf M., van der Laarse A., Schalij M., et al. Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin. Cardiovasc Res 67 (2005) 245-255
43. + progenitor cells after cardiac surgery [miscellaneous article]. Circulation (Cardiovascular Surgery Supplement) 114 (2006) I-192
44. + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110 (2004) 3213-3220
45. Massa M., Rosti V., Ferrario M., Campanelli R., Ramajoli I., Rosso R., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105 (2005) 199-206
46. Kucia M., Dawn B., Hunt G., Guo Y., Wysoczynski M., Majka M., et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 95 (2004) 1191-1199
47. + stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur Heart J 27 (2006) 283-289
48. Liew C.-C., Ma J., Tang H.-C., Zheng R., and Dempsey A. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 147 (2006) 126-132
49. Burczynski M., and Dorner A. Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies. Pharmacogenomics 7 (2006) 187-202
50. Seiler P.-U., Stypmann J., Breithardt G., and Schulze-Bahr E. Real-time RT-PCR for gene expression profiling in blood of heart failure patients-a pilot study. Basic Res Cardiol V99 (2004) 230-238
51. Moore D., Li H., Jeffries N., Wright V., Cooper Jr. R., Elkahloun A., et al. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation 111 (2005) 212-221